治瘫灵治疗老年中风恢复期及后遗症的临床研究

The clinical Study on Treatment of senile stroke in Recovery and Sequela Stage with "Zhitanling

将315例老年中风恢复期及后遗症患者,随机分治疗组(Ⅰ组)和对照组(Ⅱ组),两组分别服用治瘫灵胶囊和维脑路通片剂,疗程8周。结果:Ⅰ组明显优于Ⅱ组,总有效率分别为83.49％和54.37％,差异显著(p<0.01)。Ⅰ组对神经功能缺损的改善优于Ⅱ组;对全血粘度、血浆比度粘度、血小板粘附、血栓弹力图、体外血栓长度等药后有显著改善(p<0.01),Ⅱ组无明显变化。48例服用治瘫灵患者治疗前后行颅CT检查,18例梗塞面积缩小,占37.50％。

315 cases of senile stroke in recovery and sequela stage was randomly divided into the treated group ( Ⅰ group) and the control group ( Ⅱ group).The two groups were treated with 'Zhitanling' and 'Weinaolutong tabets' respectively, and each course of treatment was eight weeks. The results showed that; the Ⅰ group was obviously superior to the Ⅱ group, and the total effective rate was 88. 49%and 54. 37% respectively (p< 0.01). The Ⅰ group was superior to the Ⅱ group in improving the defect of nervous function;After treatment, in the Ⅰ group the whole blood viscosity, the plasma viscosity, the platelet adhesiveness , the thrombus elasic force graph and the extrinsic thrombus length were improved obviously (p<0. 01), but those in the n group hadn't obviously changed. Out of 48 cases which were detected by cranial CT before and after treating with 'Zhitanling', 18 cases's infarct areas had reduced (37.5%).